Skip to main content

Table 3 Comparisons between patients with and without abdominal obesity presented for each sex

From: Midnight salivary cortisol secretion and the use of antidepressants were associated with abdominal obesity in women with type 1 diabetes: a cross sectional study

 

Abdominal obesity

Women

Men

Yes

No

p a

Yes

No

p a

N

21

65

 

8

96

 

Age (years)

45 (32, 50)

40 (31, 51)

0.81

52 (37, 58)

44 (32, 52)

0.17

Diabetes duration (years)

23 (13, 28)

18 (9, 29)

0.59

20 (10, 44)

21 (12, 33)

0.90

MSCb (nmol/l)

7.1 (5.1, 8.8)

5.0 (2.9, 7.8)

0.030

3.8 (2.5, 5.4)

4.8 (3.1, 7.2)

0.37

MSCb

 Highc

13 (62)

24 (37)

0.007f

1 (12)

26 (27)

0.29f

 Intermediated

7 (33)

17 (26)

3 (38)

37 (38)

 Lowe

1 (5)

24 (37)

4 (50)

33 (34)

 Smokingg

1 (5)

4 (6)

> 0.99h

1 (12)

10 (11)

> 0.99h

 Physical inactivityi

4 (19)

5 (8)

0.22h

0

10 (11)

> 0.99h

Physical activityi

(times per week)

 > 5

7 (33.3)

25 (41)

0.31f

2 (25)

35 (38)

0.82f

 3–5

7 (33.3)

20 (33)

3 (37.5)

29 (31)

 1–2

3 (14.3)

11 (18)

3 (37.5)

19 (20)

 < 1

4 (19)

5 (8)

0

10 (11)

Depression

2 (10)

6 (9)

> 0.99h

2 (25)

10 (10)

0.23h

Alexithymia

6 (29)

11 (17)

0.34h

3 (38)

10 (10)

0.060h

Antidepressants

6 (29)

3 (5)

0.006h

0

4 (4)

> 0.99h

  1. Data are n (%) or median (q1, q3). aMann–Whitney U test unless otherwise indicated. bMidnight salivary cortisol, c≥ 6.7 nmol/l, d≥ 3.7 to  < 6.7 nmol/l, e< 3.7 nmol/l. fLinear-by-linear association. Missing values (women/men): gn = 3/2. h Fisher’s exact test. Missing values (women/men): in = 4/3